Snyder Mark Howard bought HALO

February 20, 2026 · Form 4 insider transaction

Snyder Mark Howard bought 5,332 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.